MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…
  • 2019 International Congress

    Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

    H. Jeong, H. Kang (Changwon, Republic of Korea)

    Objective: Investigate the relationship between global and specific cognitive functions and PIGD symptoms in Parkinson’s disease Background: It is well known that cognition and motor…
  • 2019 International Congress

    Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

    A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…
  • 2019 International Congress

    Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

    D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

    Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…
  • 2019 International Congress

    Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

    Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…
  • 2019 International Congress

    A videographic tool for quantitative assessment of the Glabellar Reflex

    A. Braczynski, J. Schulz, S. Leonhardt, C. Hoog Antink (Aachen, Germany)

    Objective: We developed a videographic tool to quantitatively assess the Glabellar Reflex (GR) in healthy patients for further analysis in Parkinson (PD) patients. Background: The…
  • 2019 International Congress

    Neural plasticity based on the change of the glutamate receptors: Repetition of electrical stimulation for the reduction of Parkinsonian symptoms

    GT. Kim, N. Nguyen, KS. Kim (Incheon, Republic of Korea)

    Objective: This study investigated the fundamental mechanism how the repeated electrical stimulation (ES) affects the reduction of parkinsonian symptoms. Background: The reduced parkinsonian symptoms by…
  • 2019 International Congress

    The role of lipid metabolism in mouse models of Parkinson’s disease

    M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

    Objective: To investigate the role of lipid metabolism and the effect of blocking carnitine palmitoyl-transferase 1 (CPT1) in toxic and genetically mouse models of Parkinson’s…
  • 2019 International Congress

    Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

    V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

    Objective: The objective of the study was to determine whether PD prevalence exhibit any spatial dependence in order to get hypothesis on PD risk or…
  • 2019 International Congress

    Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain

    K. Methawasin, R. Suppawat, P. Petborom, M. Wongwandee, S. Rungruanghiranya, T. Asawavichienjinda (Ongkharak, Thailand)

    Objective: To find out phenotypes of movement disorders related to COPD, and also associated factors. Background: Movement disorders in systemic diseases exactly are common in…
  • « Previous Page
  • 1
  • …
  • 160
  • 161
  • 162
  • 163
  • 164
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley